Egypt Approval Granted!

MedPark has obtained regulatory approval from the Egyptian Drug Authority (EDA) in Egypt for  MedPark Bone S1, BOSS, and COLLA.

With this approval, we have further strengthened our competitiveness and credibility in the global market.

MedPark continues to expand its product supply chain, demonstrate the competitiveness of its products, 

and provide safe and functional biomaterials as well as sustainable regenerative solutions.